EXPRES2ION BIOTECH (Germany) Performance
| 5JD Stock | EUR 1.77 0.06 3.28% |
The firm shows a Beta (market volatility) of -0.75, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning EXPRES2ION BIOTECH are expected to decrease at a much lower rate. During the bear market, EXPRES2ION BIOTECH is likely to outperform the market. EXPRES2ION BIOTECH HLDG currently shows a risk of 12.76%. Please confirm EXPRES2ION BIOTECH HLDG information ratio, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if EXPRES2ION BIOTECH HLDG will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Weak
Over the last 90 days EXPRES2ION BIOTECH HLDG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly fragile basic indicators, EXPRES2ION BIOTECH may actually be approaching a critical reversion point that can send shares even higher in January 2025. ...more
EXPRES2ION |
EXPRES2ION BIOTECH Relative Risk vs. Return Landscape
If you would invest 260.00 in EXPRES2ION BIOTECH HLDG on September 23, 2024 and sell it today you would lose (83.00) from holding EXPRES2ION BIOTECH HLDG or give up 31.92% of portfolio value over 90 days. EXPRES2ION BIOTECH HLDG is currently producing 0.1096% returns and takes up 12.7641% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than EXPRES2ION, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
EXPRES2ION BIOTECH Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EXPRES2ION BIOTECH's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as EXPRES2ION BIOTECH HLDG, and traders can use it to determine the average amount a EXPRES2ION BIOTECH's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0086
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | 5JD |
| Negative Returns |
Estimated Market Risk
| 12.76 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average EXPRES2ION BIOTECH is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EXPRES2ION BIOTECH by adding EXPRES2ION BIOTECH to a well-diversified portfolio.
EXPRES2ION BIOTECH Fundamentals Growth
EXPRES2ION Stock prices reflect investors' perceptions of the future prospects and financial health of EXPRES2ION BIOTECH, and EXPRES2ION BIOTECH fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EXPRES2ION Stock performance.
| Return On Equity | -0.57 | |||
| Return On Asset | -0.34 | |||
| Shares Outstanding | 37.15 M | |||
| Debt To Equity | 0.02 % | |||
About EXPRES2ION BIOTECH Performance
By analyzing EXPRES2ION BIOTECH's fundamental ratios, stakeholders can gain valuable insights into EXPRES2ION BIOTECH's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if EXPRES2ION BIOTECH has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if EXPRES2ION BIOTECH has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. EXPRES2ION BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 17 people.Things to note about EXPRES2ION BIOTECH HLDG performance evaluation
Checking the ongoing alerts about EXPRES2ION BIOTECH for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EXPRES2ION BIOTECH HLDG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EXPRES2ION BIOTECH had very high historical volatility over the last 90 days | |
| EXPRES2ION BIOTECH may become a speculative penny stock | |
| EXPRES2ION BIOTECH has high likelihood to experience some financial distress in the next 2 years |
- Analyzing EXPRES2ION BIOTECH's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EXPRES2ION BIOTECH's stock is overvalued or undervalued compared to its peers.
- Examining EXPRES2ION BIOTECH's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EXPRES2ION BIOTECH's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EXPRES2ION BIOTECH's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EXPRES2ION BIOTECH's stock. These opinions can provide insight into EXPRES2ION BIOTECH's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for EXPRES2ION Stock analysis
When running EXPRES2ION BIOTECH's price analysis, check to measure EXPRES2ION BIOTECH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXPRES2ION BIOTECH is operating at the current time. Most of EXPRES2ION BIOTECH's value examination focuses on studying past and present price action to predict the probability of EXPRES2ION BIOTECH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXPRES2ION BIOTECH's price. Additionally, you may evaluate how the addition of EXPRES2ION BIOTECH to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |